UNCY

Unicycive Therapeutics (UNCY)

About Unicycive Therapeutics (UNCY)

Unicycive Therapeutics, Inc. engages in the development of treatment for kidney diseases. Its products include UNI-494, Renazorb, and UNI-220. The company was founded by Shalabh Gupta on August 18, 2016 and is headquartered in Los Altos, CA.

Details

Daily high

$0.69

Daily low

$0.63

Price at open

$0.64

52 Week High

$1.60

52 Week Low

$0.20

Market cap

67.4M

Dividend yield

0.00%

Volume

1.9M

Avg. volume

754,182

P/E ratio

-.81

Unicycive Therapeutics News